Although
biopolymers are widely used in biomedical fields, the issue of poor
antimicrobial properties remains unsolved, leading to a potential
increase in infections. Here, ceria nanoparticles (CNPs) were incorporated
into a representative biopolymer, poly(methyl methacrylate) (PMMA),
for drug-free antimicrobial properties. After characterizing the CNPs
and surface/mechanical properties of the CNP-PMMA nanocomposite, antiadhesive
effects against Candida albicans, the most common
fungal species responsible for fungal infections, were determined
using metabolic activity assays, and the underlying microbial antiadhesive
mechanism was revealed. Hydrothermally fabricated CNPs showed a size
of ∼20 nm with a zeta potential of 12 ± 2.3 mV and showed
catalytic properties as a ROS modulator. Successful incorporation
of CNPs into PMMA up to 2 wt % was confirmed by EDS analysis. The
surface roughness and mechanical properties such as flexural strength
and modulus were relatively unchanged up to 2 wt %. In contrast, the
surface energy increased, and the Vickers hardness decreased in the
2 wt % PMMA compared with the control. A drop of up to 90% of adherent Candida albicans was observed in CNP-incorporated PMMA,
which was confirmed and quantified via fungus staining images. The
antiadhesive mechanism was revealed from the direct antimicrobial
effects of CNP via the upregulation of the intracellular ROS level.
Taken together, the antimicrobial-adhesive properties of the CNP-PMMA
nanocomposite suggest the potential usefulness of CNP as a promising
drug-free antimicrobial ingredient for biopolymers, which could lead
to the prevention of microbial-induced complications in clinical settings.